AzTrials
AzTrials

Postoperative Sore ThroatNCT07895069

The Effect of Compound Chamomile and Lidocaine Hydronchloride Gel as an Endotracheal Tube Lubricant on Postoperative Pharyngeal and Laryngeal Complications in Thoracic Surgery Patients

A study testing Polycamomile Lidocaine Gel and Lidocaine Glue in people with Postoperative Sore Throat, run by The Second Affiliated Hospital of Chongqing Medical University at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Total anesthesia is the most commonly used anesthesia method in clinical surgery, which can reduce hospital stay and improve patient comfort on the basis of ensuring patient surgery safety. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Postoperative Sore Throat
What is being tested?
Polycamomile Lidocaine Gel and Lidocaine Glue
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
330 participants
Where
1 siteChina
Study dates
1 Oct 2026to 31 Jan 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 to 65 years, ASA physical status III, BMI 18 to 30 kg/m²
  • Inpatient scheduled for thoracic resection of lung lesion
  • Mallampati airway classification I or II
  • Voluntary participant providing written informed consent

Who cannot join

  • Pregnant or lactating individuals
  • Known allergy or intolerance to the study local anesthetics
  • Severe cardiovascular, hepatic, or renal disease
  • Symptoms of upper respiratory tract infection within the prior 7 days
  • History of difficult intubation
  • Active smoking or history of chronic pharyngitis
Show all 9Show fewer
  • Prior oropharyngeal surgery
  • Investigator-assessed unsuitability for study participation for any other reason
  • Refusal to participate in the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Yuhan Wang Yuhan Wang contact

+86 18872341852

Wyh470810@163.com

China1 site
  • The Second Affiliated Hospital of Chongqing Medical University

    Chongqing, 400000

    Jie Chen, +86 13527517763, 305045@hospital.cqmu.edu

Other trials in China

About this study

Total anesthesia is the most commonly used anesthesia method in clinical surgery, which can reduce hospital stay and improve patient comfort on the basis of ensuring patient surgery safety. However, for patients with total anaesthetic tracheotomy, the incidence of throat complications such as throat pain, wheezing, and coughing after tracheotomy removal remains high. According to literature reports, the incidence of throat pain can reach 40% after total anaesthetic tracheotomy removal, the incidence of wheezing is 24%, and the related throat symptoms can persist until 24 hours or even longer after surgery. This phenomenon is particularly notable in patients with thoracic surgery.The high incidence of laryngeal pain after thoracic surgery is the result of the combination of mechanical stimulation of the bronchial / bilateral bronchial catheter, air sac pressure, surgery time and position, individual susceptibility factors of the patient, and technical details of intubation/entubation. Although such laryngeal complications are milder compared to other anesthetic complications, they can reduce the patient's post-operative hospitalization comfort and satisfaction, and even prolong the hospitalization time, affecting clinical treatment effectiveness and patient admission experience.This study aims to explore the effect of polycamomile lidocaine gel as a bronchial catheter lubricant on postoperative laryngeal complications in patients undergoing thoracic surgery. It aims to provide new ideas and clinical basis for optimizing clinical drug administration protocols and reducing the incidence of postoperative laryngeal complications for patients undergoing thoracic surgery with total anaesthetic bronchial intubation.

Being tested
Polycamomile Lidocaine Gel, Lidocaine Glue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Polycamomile Lidocaine GelDrug

    2 g of polycamomile lidocaine gel was uniformly applied from the tip of the tracheal tube to 1/3 of the front

  • Lidocaine GlueDrug

    Uniformly apply 2g lidocaine glue from tip to front 1/3 of the end of the tracheal tube

Study groups in NCT07895069
Study groupRoleWhat they receive
Complex Camomile Lidocaine groupExperimentalNot described
Receives: Drug: Polycamomile Lidocaine Gel
Lidocaine Glue groupPlacebo comparatorNot described
Receives: Drug: Lidocaine Glue

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Baseline-corrected delta in CPPS (dB) for the sustained vowel /ɑ/ stable segment at 6 hours post-extubation (ΔCPPS₆ₕ = CPPS₆ₕ - CPPSₚᵣₑ)

    Measured: Six hours after extubation

Secondary outcomes (2)
  1. The ΔCPPS values at 1, 24, and 48 hours after extubation

    Measured: 1 hour, 24 hours and 48 hours after the removal of the tracheal tube

  2. After extubation, the laryngoscope was used to grade the throat condition; the incidence of throat pain and cough was related to the grade.

    Measured: 1 hour, 24 hours, and 48 hours after extubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2026
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion31 Jan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
330 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07895069
Sponsor's protocol ID
2026-IIT-SL-159
Status last verified
Oct 2026
First submitted
11 Oct 2026
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • 郎宇,王天龙,张雁华,张敏,利多卡因凝胶作为喉罩润滑剂的临床观察•临床麻醉学杂志,2010,26(9):817-818.

  • Tanaka Y, Nakayama T, Nishimori M, Tsujimura Y, Kawaguchi M, Sato Y. Lidocaine for preventing postoperative sore throat. Cochrane Database Syst Rev. 2015 Jul 14;2015(7):CD004081. doi: 10.1002/14651858.CD004081.pub3.

    PubMed 26171894
  • Wang S, Wang H, Lei B, Xu L, Wang L, Wang G; Collaborators. Impact of Compound Chamomile and Lidocaine Hydrochloride Gel on Airway Complications Associated With Laryngeal Mask Airway: A Prospective, Multicenter, Randomized Controlled Trial. Anesth Analg. 2025 Oct 1;141(4):918-920. doi: 10.1213/ANE.0000000000007519. Epub 2025 Apr 4. No abstract available.

    PubMed 40184312

Questions about this trial

What is this clinical trial studying?

A study testing Polycamomile Lidocaine Gel and Lidocaine Glue in people with Postoperative Sore Throat, run by The Second Affiliated Hospital of Chongqing Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yuhan Wang Yuhan Wang (+86 18872341852, Wyh470810@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Baseline-corrected delta in CPPS (dB) for the sustained vowel /ɑ/ stable segment at 6 hours post-extubation (ΔCPPS₆ₕ = CPPS₆ₕ - CPPSₚᵣₑ) (time frame: Six hours after extubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07895069, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in